SGH enters three-year collaboration with Redesign Health to co-develop digital health startups addressing ageing-in-place, chronic care management, workforce productivity, and other national healthcare priorities
By : Hithaishi Bhaskar, Editor_APAC
Singapore General Hospital (SGH) has partnered with Redesign Health to accelerate healthcare innovation by co-developing digital health startups focused on national priorities like ageing-in-place, chronic care, and workforce productivity. This three-year collaboration leverages SGH's clinical expertise and Redesign Health's capital, AI-enabled platform, and domain knowledge to scale solutions across Asia and globally.
Healthcare professionals often identify areas for improving patient care and experience but need the right partnerships to turn ideas into actionable changes. Similarly, startups with innovative healthcare solutions may struggle to gain insights from reputable hospitals to develop, refine, or validate their ideas before scaling them beyond Singapore.
To address these challenges, Singapore General Hospital (SGH), a globally top-ranked hospital, has partnered with Redesign Health Inc., a global venture and applied technology firm, to connect healthcare professionals, startups, and other stakeholders. This collaboration aims to tackle critical healthcare challenges in Singapore and the broader region by fostering innovation and collaboration within the healthcare ecosystem.
The three-year partnership, formalized through a Memorandum of Understanding (MOU) signed in December 2025, will co-develop healthcare startups that are aligned with national and institutional healthcare priorities, including:
● Value-based and outcome-driven care models
● Ageing-in-place and chronic care management
● Workforce productivity, retention, and automation
● Distributed care models (e.g., IoT, remote monitoring, ambulatory care)
● Financial protection and health system sustainability
● Precision medicine and data-driven innovation
● Ventures leveraging SGH’s intellectual property (IP) and patents
Under the MOU, SGH will provide access to clinicians, research, and innovation teams, as well as inputs on product design, safety, and clinical relevance. The hospital will also support pilot programmes, workflow integration, data validation, and other areas where its clinical...
English (US)